Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
O'REILLY, MICHAEL
One or more keywords matched the following items that are connected to O'REILLY, MICHAEL
Item TypeName
Academic Article Phase I study of recombinant human endostatin in patients with advanced solid tumors.
Academic Article Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin.
Concept Angiogenesis Inhibitors
Academic Article Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice.
Academic Article Antiangiogenic antithrombin.
Academic Article Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis.
Academic Article The combination of antiangiogenic therapy with other modalities.
Academic Article Quantitative analysis of biomarkers defines an optimal biological dose for recombinant human endostatin in primary human tumors.
Academic Article Radiation combined with antiangiogenic and antivascular agents.
Academic Article Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis.
Academic Article Antiangiogenesis and vascular endothelial growth factor/vascular endothelial growth factor receptor targeting as part of a combined-modality approach to the treatment of cancer.
Academic Article The interaction of radiation therapy and antiangiogenic therapy.
Academic Article Angiostatin inhibits and regresses corneal neovascularization.
Academic Article Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade.
Academic Article Therapeutic strategies using inhibitors of angiogenesis.
Search Criteria
  • Angiogenesis Inhibitors